- Home
- SYBX vs SMSI Comparison
SYBX vs SMSI Comparison
Compare SYBX & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- SMSI
- Stock Information
- Founded
- SYBX N/A
- SMSI 1982
- Country
- SYBX United States
- SMSI United States
- Employees
- SYBX N/A
- SMSI N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- SYBX Health Care
- SMSI Technology
- Exchange
- SYBX Nasdaq
- SMSI Nasdaq
- Market Cap
- SYBX 16.4M
- SMSI 14.3M
- IPO Year
- SYBX N/A
- SMSI 1995
- Fundamental
- Price
- SYBX $1.46
- SMSI $0.70
- Analyst Decision
- SYBX
- SMSI Strong Buy
- Analyst Count
- SYBX 0
- SMSI 1
- Target Price
- SYBX N/A
- SMSI $5.00
- AVG Volume (30 Days)
- SYBX 53.6K
- SMSI 276.6K
- Earning Date
- SYBX 08-07-2025
- SMSI 08-06-2025
- Dividend Yield
- SYBX N/A
- SMSI N/A
- EPS Growth
- SYBX N/A
- SMSI N/A
- EPS
- SYBX N/A
- SMSI N/A
- Revenue
- SYBX N/A
- SMSI $18,658,000.00
- Revenue This Year
- SYBX N/A
- SMSI $10.12
- Revenue Next Year
- SYBX N/A
- SMSI $63.12
- P/E Ratio
- SYBX N/A
- SMSI N/A
- Revenue Growth
- SYBX N/A
- SMSI N/A
- 52 Week Low
- SYBX $0.90
- SMSI $0.52
- 52 Week High
- SYBX $1.96
- SMSI $1.95
- Technical
- Relative Strength Index (RSI)
- SYBX 52.54
- SMSI 43.80
- Support Level
- SYBX $1.33
- SMSI $0.65
- Resistance Level
- SYBX $1.67
- SMSI $0.72
- Average True Range (ATR)
- SYBX 0.12
- SMSI 0.06
- MACD
- SYBX -0.01
- SMSI 0.01
- Stochastic Oscillator
- SYBX 38.24
- SMSI 30.00
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.